Defense Technologies International Corp 10-Q for FY2023 Q2
Defense Technologies International Corp. (DTII)
About this 10-Q
Defense Technologies International Corp filed this 10-Q on December 20, 2022, covering the quarter ended October 31, 2022 (FY2023 Q2).
Headline figures
Quarter ended October 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net income
- $122.43K
- down 62.3% from net income of $324.7K a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number
(Exact name of registrant as specified in its charter)
(State of Incorporation) | (I.R.S. Employer Identification Number) |
(Address of principal executive offices)
(
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
[X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company
Large accelerated filer | [ ] | Accelerated filer | [ ] |
[X] | Smaller reporting company | ||
|
| Emerging Growth Company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
As of December 19, 2022, there were
1
DEFENSE TECHNOLOGIES INTERNATIONAL CORP.
FORM 10-Q
FOR THE THREE AND SIX MONTH PERIODS ENDED OCTOBER 31, 2022 AND 2021
TABLE OF CONTENTS
| PART I — FINANCIAL INFORMATION | Page |
|
|
|
Item 1. |
| |
|
|
|
| 3 | |
|
|
|
| Condensed Consolidated Statements of Operations for the Three and Six Month Periods Ended October 31, 2022 and 2021 (Unaudited) | 4 |
|
|
|
| 5 | |
|
|
|
| Condensed Consolidated Statements of Cash Flows for the Six Month Periods Ended October 31, 2022 and 2021 (Unaudited) | 6 |
|
|
|
| 7 | |
|
|
|
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 16 |
|
|
|
Item 3. | 18 | |
|
|
|
Item 4. | 18 | |
|
|
|
| PART II — OTHER INFORMATION |
|
|
|
|
Item 1. | 19 | |
|
|
|
Item 1A. | 19 | |
|
|
|
Item 2 | Unregistered Sales of Equity Securities and Use of Proceeds. | 19 |
|
|
|
Item 3. | 19 | |
|
|
|
Item 4. | 19 | |
|
|
|
Item 5. | 19 | |
|
|
|
Item 6. | 20 | |
|
|
|
20 | ||
2
PART I — FINANCIAL INFORMATION
Item 1.Financial Statements
Defense Technologies International Corp. and Subsidiary | ||
Condensed Consolidated Balance Sheets | ||
October 31, 2022 | April 30, 2022 | |
| (Unaudited) | (Audited) |
ASSETS |
|
|
Current assets: |
|
|
Cash | $ | $ |
Inventory | ||
Total current assets | ||
|
|
|
Fixed assets, net of depreciation of $ | ||
Total assets | $ | $ |
|
|
|
| ||
Current liabilities: |
|
|
Accounts payable and accrued expense | $ | $ |
Accrued licenses agreement payable | ||
Accrued interest and fees payable | ||
Convertible notes payable, net of discount | ||
Derivative liabilities | ||
Payables – related parties | ||
Customer deposits | ||
Notes payable | ||
Note payable- related party | ||
Total current liabilities | ||
|
|
|
Total liabilities | ||
|
|
|
Commitments and Contingencies | ||
|
|
|
Stockholders’ deficit: |
|
|
Preferred stock, $ | ||
Series B –– | ||
Series D – | ||
Common stock, $ | ||
Additional paid-in capital | ||
Shares authorized but not issued | ||
Accumulated deficit | ( | ( |
Total | ( | ( |
Non-controlling interest | ( | ( |
Total stockholders’ deficit | ( | ( |
|
|
|
Total liabilities and stockholders’ deficit | $ | $ |
See notes to condensed consolidated financial statements
3
Defense Technologies International Corp. and Subsidiary |
Condensed Consolidated Statements of Operations |
As of October 31, |
(Unaudited) |
| Three Months | Six Months | ||
2022 | 2021 | 2022 | 2021 | |
Expenses: |
|
|
|
|
Depreciation | $ | $ | $ | $ |
Consulting | ||||
Development | ||||
General and administrative | ||||
|
|
|
|
|
Total expenses | ||||
|
|
|
|
|
Loss from operations | ( | ( | ( | ( |
|
|
|
|
|
Other income (expense): |
|
|
|
|
Interest and other income (expense) | ( | ( | ( | ( |
Gain (loss) on debt settlement | ( | |||
Gain (loss) on derivative liability | ||||
Finance cost | ( | ( | ||
Inventory adjustment | ||||
Interest- note discount | ( | ( | ( | |
|
|
|
|
|
Total other income (expense) | ( | ( | ||
|
|
|
|
|
Income (loss) before income taxes | ( | ( | ||
|
|
|
|
|
Provision for income taxes | ||||
|
|
|
|
|
Net income (loss) before non-controlling interest | ( | ( | ||
|
|
|
|
|
Non- controlling interest in net loss of the consolidated subsidiary | ||||
|
|
|
|
|
Net income (loss) attributed to the Company | $ | $ | $( | $( |
|
|
|
|
|
Net income (loss) per common share: Basic and dilutive | $ | $ | $( | $( |
Weighted average common shares outstanding: |
|
|
|
|
Basic and dilutive | ||||
See notes to condensed consolidated financial statements
4
Defense Technologies International Corp. and Subsidiary
Condensed Consolidated Statements of Stockholders’ Deficit
For the Three And Six Months Ended October 31, 2022 and 2021
(Unaudited)
| Preferred stock |
| Common Stock | Additional | Accumulated | Non-Controlling | Shares | Total Stockholders’ | ||
Shares | Amount |
| Shares | Amount | Capital | Deficit | Interest | Issued | Deficit | |
Balance at April 30, 2021 |
| ( | ( | ( | ||||||
Common stock issued for debt |
| |||||||||
Retirement of derivative at conversion |
| |||||||||
Common stock issued for Series C preferred | ( |
| ||||||||
Temporary equity- preferred shares- issued |
| |||||||||
Capitalize funding and dividend |
| ( | ( | |||||||
Net loss |
| ( | ( | ( | ||||||
Balance at July 31, 2021 | $ |
| $ | $ | $( | $( | $( | |||
Common stock issued for debt |
| |||||||||
Common stock issued for mezzanine conversion | ( |
| ||||||||
Retirement of debt at conversion |
| |||||||||
Capitalize funding and dividend |
| ( | ( | |||||||
Temporary equity- preferred shares issued |
| |||||||||
Net loss |
| ( | ||||||||
Balance at October 31, 2021 | $ |
| $ | $ | $( | $( | $( | |||
|
|
|
|
|
|
|
|
|
|
|
Balance at April 30, 2022 (Reclassified) |
| ( | ( | ( | ||||||
Preferred B shares issued for accrued expense – related parities |
| |||||||||
Preferred B shares issued for notes payable |
| |||||||||
Preferred B shares issued for accounts payable and accrued expenses |
| |||||||||
Preferred shares issued for service not issued |
| |||||||||
Loss on debt settlement, accruals and/accounts payable |
| |||||||||
Rounding of common stock on reverse split |
| ( | ||||||||
Dividends on Series D preferred |
| ( | ||||||||
Net loss |
| ( | ( | ( | ||||||
Balance at July 31, 2022 | $ |
| $ | $ | $( | $( | $( | |||
Common stock issued for debt conversion |
| |||||||||
Preferred shares issued for service |
| |||||||||
Common stock issued for preferred share conversion | ( |
| ( | |||||||
Dividends on Series D preferred |
| ( | ||||||||
Net loss |
| ( | ||||||||
Balance at October 31, 2022 | $ |
| $ | $ | $( | $( | $( | |||
See notes to condensed consolidated financial statements
5
Defense Technologies International Corp and Subsidiaries |
Condensed Consolidated Statements of Cash Flows |
(Unaudited) |
| Six Months Ended October 31, | |
2022 | 2021 | |
Cash flows from operating activities: |
|
|
Net income (loss) | $( | $( |
Adjustments to reconcile net income (loss) to net cash |
|
|
Preferred shares issued for service | ||
Amortization of debt discount to interest expense | ||
(Gain) loss on settlement of accrued payments | ||
(Gain) loss on derivative liability | ( | ( |
Depreciation | ||
Change in operating assets and liabilities: |
|
|
( Increase) decrease in inventory | ( | ( |
Increase (decrease) in accounts payable and accrued expenses | ||
Increase in payables – related parties | ||
Net cash provided by (used in) operating activities | ( | ( |
|
|
|
Cash flows from financing activities |
|
|
Proceeds from notes payable- related party | ||
Repayment of notes payable | ( | ( |
Proceeds from Series C preferred shares | ||
|
|
|
Net cash provided by financing activities | ||
|
|
|
Net increase (decrease) in cash | ( | |
|
|
|
Cash at beginning of period | ||
Cash at end of period | $ | $ |
|
|
|
Supplement Disclosures |
|
|
Interest Paid | $ | $ |
Income tax Paid | $ | $ |
|
|
|
Noncash financing and investing activities |
|
|
Retirement of derivative at debt conversion | $ | $ |
Interest accrued on preferred shares | $ | $ |
Common stock issued for convertible debt | $ | $ |
Common stock issued for conversion of series C preferred | $ | $ |
Series B preferred issued for notes payable and accrued interest | $ | $ |
Series B preferred issued for accrued expense | $ | $ |
Series B preferred issued for accrued expense – relate parties | $ | $ |
|
|
|
See notes to condensed consolidated financial statements
6
Defense Technologies International Corp. and Subsidiary
Notes to Condensed Consolidated Financial Statements
As of October 31, 2022
(Unaudited)
NOTE -1: BASIS OF PRESENTATION AND ORGANIZATION
Defense Technologies International Corp. (the "Company ") was incorporated in the State of
On October 19, 2016, the Company entered into a Definitive Agreement with Controlled Capture Systems, LLC (“CCS”), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement. Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements. The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties as defined in the Definitive Agreement. On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to the market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive (3)Invoices for parts and materials will be billed separate of the license fees noted above.
Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company. The Company currently owns 76.28% of PSSI with 23.72% acquired by several individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI.
On June 28, 2022 the Company’s common shares were reversed with each shareholder receiving one share of common stock for each 500 shares held before the reverse split. The number of shares throughout the disclosure have been retrospectively adjusted to represent the number of shares after the reverse split.
Basis of Presentation
These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year end is April 30.
The interim condensed consolidated financial statements have been prepared without audit in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q. They do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended April 30, 2022 included in its Annual Report on Form 10-K filed with the SEC.
7
The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s consolidated financial position as of October 31, 2022, the consolidated results of its operations and its consolidated cash flows for the three months ended October 31, 2022 and 2021. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full fiscal year.
Consolidation and Non-Controlling Interest
These consolidated financial statements include the accounts of the Company, and its majority-owned subsidiary, PSSI, from its formation on January 12, 2017 to date. All inter-company transactions and balances have been eliminated.
Reclassification
During the six months period ended October 31, 2022, the Company reclassified 25,000 preferred series B shares to be issued from issued as the shares had not been issued as of the date of reporting. The share reduced paid in capital previously reported.
Inventory
Inventories are stated at the lower of cost using the first-in, first-out (FIFO) cost method of accounting. Inventories as of October 31, 2022 consist of parts used in assembly of the units being sold plus work in progress and finished goods. As of October 31, 2022 the value of the inventory was $
Equipment
Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
8
Impairment of Long-Lived Assets
We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.
Net Income (Loss) per Common Share
Basic net income or loss per common share is calculated by dividing the Company’s net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per common share is calculated by dividing the Company’s net income or loss by sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding stock options and warrants, using the treasury stock method and the average market price per share during the period, and conversion of convertible debt, using the if converted method. As of October 31, 2022, the Company had potential shares issuable under convertible preferred shares and convertible debt for a total of 13,028,034.
Recent Accounting Pronouncements
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2020-06 Debt with Conversion and Other Options (Subtopic 470-20) and Derivative and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contract’s in an Entity’s own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for it. The ASU simplifies the diluted net income per share calculation in certain areas. The ASU is effective for annual and interim periods has been amended for small businesses to beginning after December 15, 2023 as early adoption was permitted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. The Company evaluated there is no impact this new guidance will have on its financial statements.
NOTE- 2: GOING CONCERN
These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern. Through October 31, 2022, the Company had no revenues, has accumulated deficit of $
Management plans to continue to provide for the Company's capital needs during the year ending April 30, 2022 by issuing debt and equity securities and by the continued support of its related parties. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.
9
NOTE – 3: INVESTMENTS
Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company for 17,500 shares of PSSI valued at $378,600 for 76.28% of PSSI. The balance of PSSI was acquired by four individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI. The investment was impaired as of April 30, 2019.
NOTE -4: RELATED PARTY TRANSACTIONS
Management and administrative services are currently compensated as per a Service Agreement between the Company and its Chief Executive Officer and Director executed on April 25, 2016 and a Service Agreement with the subsidiary PSSI executed on January 12, 2017, a Service Agreement between the Company and a Director executed on May 20, 2016, and an Administration Agreement with a related party executed on March 15, 2011 and renewed on May 1, 2017 and renewed in August 21, 2020 plus the assumption of a Service Agreement with the subsidiary PSSI assumed on January 12, 2017 and renewed on August 21, 2020, whereby the fee is based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with common stock. The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay. These types of transactions, when incurred, result in payables to related parties in the Company’s consolidated financial statements as a necessary part of funding the Company’s operations.
On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of October 31, 2022, the outstanding balance on the loan agreement was $97,000 plus accrued interest.
During the six months period ending October 31, 2022 the Company issued
As of October 31, 2022 and April 30, 2022, the Company had payable balances due to related parties totaling $
NOTE – 5: NOTES PAYABLE
On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $
On July 6, 2018, the Company signed an investment agreement with a third party. Under the terms of the agreement the Company received $
10
On July 18, 2018, the Company entered into a promissory note of $
On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of October 31, 2022, the outstanding balance on the loan agreement was $
As of October 31, 2022 and April 30, 2022 the outstanding balances of notes payable was $
NOTE – 6: CONVERTIBLE DEBT
On March 10, 2016, the Company entered into a convertible promissory note for $
On August 3, 2016, the Company entered into a convertible promissory note with an institutional investor for $
On February 16, 2018 Passive Security Scan Inc, a subsidiary of the Company, issued a $
On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $
On October 4, 2018, the Company entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes issued by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception. The agreement resulted in a new note for $
On March 10, 2022, the Company issued 657,895 shares of series A preferred with a value of $
11
On March 22, 2022, the Company entered into a one year convertible promissory note for $
During the six months ended October 31, 2021 the Company issued
During the six months period ended October 31, 2022 the Company issued
As of October 31, 2022, and April 30, 2022, the convertible debt outstanding, net of discount, was $
NOTE – 7: FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES
As defined in (Financial Accounting Standards Board ASC 820), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).
The three levels of the fair value hierarchy are as follows:
Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.
Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.
12
As of October 31, 2022, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration of these instruments.
The following table represents the change in the fair value of the derivative liabilities during the three months ended October 31, 2022:
| Level 1 | Level 2 | Level 3 |
Balance at April 30, 2022 | $-- | $-- | $ |
Change in fair value of derivative liability | -- | -- | ( |
|
|
|
|
Balance at October 31, 2022 | $-- | $-- | $ |
The estimated fair value of the derivative liabilities at October 31, 2022 was calculated using the Binomial Lattice pricing model with the following assumptions:
Risk-free interest rate | |
Expected life in years | |
Dividend yield | |
Expected volatility |
NOTE – 8: EQUITY
Common Stock
On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to
During the six months ended October 31, 2021, the Company issued
During the six months ended October 31, 2021, the Company issued
During the six months ended October 31, 2022, the Company issued
Preferred Stock
The Company has
13
On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0,0001.
On February 16, 2021 and April 21, 2021, the Company issued
On June 4, 2021, the Company issued
During the six months ended October 31, 2021 the Company issued
During the six month period ended October 31, 2022, the Company issued
During the six months period ended October 31, 2022 the Company issued
As of October 31, 2022 the Company had
NOTE – 9: COMMITMENTS AND CONTINGENCIES
The Company has the following material commitments as of October 31, 2022:
a) | Administration Agreement with EMAC Handel’s AG, renewed effective May 1, 2017 for a period of three years and amended May 1, 2021. Monthly fee for administration services of $ |
b) | Service Agreement signed April 25, 2016 with Merrill W. Moses, President, Director and CEO, for services of $ |
c) | Service Agreement signed May 20, 2016 with Charles C. Hooper, Director, for services of $ |
d) | Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handel Investments AG, for general fees of $ |
14
e) | Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $ |
f) | Business Development and Consulting Agreement of PSSI signed January 15, 2017 with WSMG Advisors, Inc., for finder’s fees of 10% of funding raised for PSSI and the issuance of 1,000 common shares of PSSI. |
On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows.
·Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter.
·All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive.
·Invoices for parts and materials will be billed separate of the license fees noted above.
NOTE - 10: SUBSEQUENT EVENTS
On November 1, 2022 the Company issued 27,356 shares of common stock for the conversion of 4 shares of series D with a value of $4,103.
On November 15,2022, the company cancelled the sales license agreement with Virexit technologies, Inc.
On November 17, 2022 the Company issued 29,350 shares of common stock for 2,935 shares of series B preferred shares with a value of $8,071.
On November 15, 2022 the Company issued 9,333 shares of series B preferred with a value of $17,500 for the settlement of consulting fees and cancellation of the consulting agreement with Privateer Market Force, Inc.
On November 18, 2022 the Company cancelled a sales License agreement with Care, Inc.
The Company has evaluated subsequent events to determine events occurring after October 31, 2022 through the filing of this report that would have a material impact on the Company’s financial results or require disclosure other than those noted above.
15
Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations
Overview
The following information should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q.
Defense Technologies International Corp. (the "Company ") was incorporated in the State of Delaware on May 27, 1998. Effective June 15, 2016, the Company changed its name to Defense Technologies International Corp. from Canyon Gold Corp. to more fully represent the Company's expansion goals into the advanced technology sector.
On October 19, 2016, the Company entered into a Definitive Agreement with Controlled Capture Systems, LLC (“CCS”), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement. Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products, and improvements. The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties as defined in the Definitive Agreement.
On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive.
Effective January 12, 2017, Passive Security Scan, Inc. ("PSSI") was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company. The Company owns 79.8% of PSSI with 20.2% acquired by several individuals and entities. The Company plans to continue the development of the technology. All sales and marketing activities are through PSSI.
The extent to which the COVID-19 pandemic may directly or indirectly impact our business, financial condition, and results of operations is highly uncertain and subject to change. We considered the potential impact of the COVID-19 pandemic on our estimates and assumptions and there was not a material impact to our consolidated financial statements as of and for the six months ended October 31, 2022.
The Company’s security products are licensed from CCS and developed by the company designed for personal and collateral protection. Products derived from this technology are intended to provide passive security scanning units for either walk-through or hand-held use to improve security for schools and other public facilities. Passive Portal units use electromagnets and do not emit anything (such as x-rays) through the subject. We have also completed a prototype with optional “Digital Imaging,” which will give the user of the scanner the ability to recall the entire traffic passing through the scanner at any time thereafter.
As of May 19, 2020, the Company added an IR Camera for detection of elevated body temperatures and is presently offering three products:
●PASSIVE PORTAL – Screens for Weapons only;
●PASSIVE PORTAL with EBT – Screens for Weapons and elevated body temperature;
●EBT Station – Screens for elevated body temperature only.
16
Forward Looking and Cautionary Statements
This report contains forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar terms, variations of such terms or the negative of such terms. These statements are only predictions and involve known and unknown risks, uncertainties and other factors. Although forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment, actual results could differ materially from those anticipated in such statements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.
Results of Operations
During the three and six months ended October 31, 2022 the Company had no revenue.
Our operating expenses for the three and six months ended October 31, 2022 was $362,194 and $1,302,403 compared to $205,595 and $409,875 for the same period in 2021. The increase was due primarily to higher consulting costs, which were $885,400 and higher development costs of $259,243 for the six months periods ending October 31, 2022. The Company recorded depreciation of $2,915 and $5,830 and general and administrative costs of $92,179 and $151,930 for the three and six month periods ended October 31, 2022 compared to depreciation of $2,915 and $5,830 and general and administrative expense of $82,680 and $149,045 for the same periods in 2021.
Interest expenses incurred in the three months and six months periods ended October 31, 2022 was $8,644 and expense of $51,744 compared to interest expense of $24,890 and $50,332 for the three and six month periods in 2021.
Change in derivative liability resulted in a gain of $148,030 for the six months period ended October 31, 2022, compared to a net gain of $26,820 for the same period in 2021. We estimate the fair value of the derivative for the conversion feature of our convertible notes payable using the American Binominal Lattice pricing model at the inception of the debt, at the date of conversions to equity, cash payments and at reporting date, recording a derivative liability, debt discount and a gain or loss on change in derivative liability as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, and variable conversion prices based on market prices as defined in the respective loan agreements. These inputs are subject to significant changes from period to period; therefore, the estimated fair value of the derivative liability will fluctuate from period to period and the fluctuation may be material.
Other expenses for the three and six month periods ending October 31, 2022 included interest from note discount of $22,838 and $45,676 compared to zero and $90,060 for the same periods in 2021. A loss on the settlement of debt and accruals of $835,829 for the six month period ended October 31, 2022 compared to none for the same period in 2021.
Total other expense for the three and six month periods ended October 31, 2022 was other income of $479,873 and expense of $761,063 compared to other expense of $519,707 and $121,072 for the same periods in 2021. The increase is primarily due to the loss on the settlement of debt and accruals in the six months period in 2022.
Net income and loss before non-controlling interest for the three and six month periods ended October 31, 2022 were a net income of $117,679 and net loss of $2,063,466 compared net income of $314,112 and net loss of $530,947 for the same periods in 2021. After adjusting for our consolidated subsidiary, net loss and net income for the three and six month period ended October 31, 2022 were net income of $122,430 and net loss of $2,045,189 compared to a net income of $324,703 and net loss of $510,342 for the same period in 2021.
17
Liquidity and Capital Resources
At October 31, 2022, the Company had total current assets of $103,359, and total current liabilities of $1,634,374 resulting in a working capital deficit of $1,531,015. Included in our current liabilities and working capital deficit at October 31, 2022 are derivative liabilities totaling $157,202 related to the conversion features of certain of our convertible notes payable, convertible notes of $341,803, net of discount, payables due related parties of $701,413, accounts payable and accrued expense of $119,072 and notes payables of $142,042. We anticipate that in the short term, operating funds will continue to be provided by related parties and other lenders.
During the six months ended October 31, 2022, net cash used in operating activities was $68,203 compared to cash used of $164,386 in the same period in 2021. Net cash used in 2022 consisted of net loss of $2,063,466, a gain in derivative liability of $148,030, loss on settlement of accrued expense of $835,829 and change in payables to related parties of $221,024 and accounts payable of $769,089.
During the six months ended October 31, 2022, net cash provided by financing activities was $67,000 consisting of a note payable of $97,000 offset by repayment of a note payable of $30,000.
We have had minimal revenue and paid expenses and costs with proceeds from the issuance of securities as well as by loans from investor, stockholders and other related parties.
Our immediate goal is to provide funding for the completion of the production of the Offender Alert Passive Scan licensed from CCS. The Offender Alert Passive Scan is an advanced passive scanning system for detecting and identifying concealed threats.
We have built 11 Passive Portal units, two of which were used in the previously announced BETA Test at a school near Austin Tx and 5 were sold. The units have been tested multiple times and performed with a 100% success every time. We are confident that upon the successful conclusion of the Beta Test, we will receive the first orders from school districts that will generate initial revenues to the Company.
We believe a related party and other lenders will provide sufficient funds to carry on general operations in the near term and fund DTC’s production and sales. We expect to raise additional funds from the sale of securities, stockholder loans and convertible debt. However, we may not be successful in our efforts to obtain financing to carry out our business plan.
See the notes to our condensed consolidated financial statements for a discussion of recently issued accounting pronouncements that we have either implemented or that may have a material future impact on our financial position or results of operations.
Off-Balance Sheet Arrangements
We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
This item is not required for a smaller reporting company.
Item 4.Controls and Procedures.
Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our management including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
18
Exchange Act of 1934) (“Exchange Act”). Based on this evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, in a manner that allows timely decisions regarding required disclosures.
We operate with a limited number of accounting and financial personnel. Although we retain the services of an experienced certified public accountant, we have been unable to implement proper segregation of duties over certain accounting and financial reporting processes, including timely and proper documentation of material transactions and agreements. We believe these control deficiencies represent material weaknesses in internal control over financial reporting.
Despite the material weaknesses in financial reporting noted above, we believe that our consolidated financial statements included in this report fairly present our financial position, results of operations and cash flows as of and for the periods presented in all material respects.
Changes in Internal Control over Financial Reporting. There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II — OTHER INFORMATION
Item 1.Legal Proceedings
There are no material pending legal proceedings to which we are a party or to which any of our property is subject and, to the best of our knowledge, no such actions against us are contemplated or threatened.
Item 1A.Risk Factors
This item is not required for a smaller reporting company.
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
During the six months ended October 31, 2022 the Company issued 27,439 shares of common stock for the conversion of $9,000 of convertible debt.
During the six months ended October 31, 2022 the Company issued 73,350 shares of common stock for the conversion of 8 shares of preferred stock with a value of $132,490.
Item 3.Defaults Upon Senior Securities
This item is not applicable.
Item 4.Mine Safety Disclosure
This item is not applicable.
Item 5.Other Information
Not applicable
19
Item 6.Exhibits
The following exhibits are filed as part of this report:
Exhibit No. |
| Description of Exhibit |
31.1 |
| Section 302 Certification of Chief Executive Officer and Chief Financial Officer |
32.1 |
| Section 1350 Certification of Chief Executive Officer and Chief Financial Officer |
101 INS* |
| XBRL Instance Document |
101SCH* |
| XBRL Taxonomy Extension Schema |
101 CAL* |
| XBRL Taxonomy Extension Calculation Linkbase |
101 DEF* |
| XBRL Taxonomy Extension Definition Linkbase |
101 LAB* |
| XBRL Taxonomy Extension Label Linkbase |
101 PRE* |
| XBRL Taxonomy Extension Presentation Linkbase |
* The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Exchange Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| DEFENSE TECHNOLOGIES INTERNATIONAL CORP. | |
|
|
|
|
|
|
|
|
|
Date: December 19, 2022 | By: | /S/ MERRILL W. MOSES |
|
| Merrill W. Moses |
|
| Chief Executive Officer |
|
| Acting Chief Financial Officer |
20
Exhibit 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Merrill W. Moses, certify that:
1.I have reviewed this quarterly report on Form 10-Q of DEFENSE TECHNOLGIES INTERNATIONAL CORP.
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: December 19, 2022
/S/ MERRILL W. MOSES
Merrill W. Moses
Chief Executive Officer
Acting Chief Financial Officer
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of DEFENSE TECHNOLGIES INTERNATIONAL CORP. (the “Company”) on Form 10-Q for the period ending October 30,2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Merrill W. Moses, Chief Executive Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/S/ MERRILL W. MOSES
Merrill W. Moses
Chief Executive Officer
Acting Chief Financial Officer
December 19, 2022
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. The foregoing certifications are accompanying the Company's Form 10-Q solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.